| RS770636513 |
MMAA
|
Health Risk |
Conflicting classifications of pathogenicity |
Methylmalonic aciduria, cblA type |
| RS770636895 |
CUBN
|
Health Risk |
Pathogenic |
Imerslund-Grasbeck syndrome, Imerslund-Grasbeck syndrome |
| RS770636921 |
USP9X
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS770636941 |
CEBPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Acute myeloid leukemia, Inborn genetic diseases |
| RS770637118 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS770637624 |
RAD51C
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS770637715 |
POLR1C
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypomyelinating leukodystrophy 11, Hypomyelinating leukodystrophy 11 |
| RS770639563 |
SLC45A2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS770640457 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilson disease, Wilson disease |
| RS770640829 |
SLC13A5
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 25 |
| RS770641163 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS770642379 |
KYNU
|
Health Risk |
Pathogenic |
Congenital NAD deficiency disorder, Vertebral |
| RS770643416 |
SPG11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia, Hereditary spastic paraplegia 11 |
| RS770644036 |
UPB1
|
Health Risk |
Likely pathogenic |
Deficiency of beta-ureidopropionase, Deficiency of beta-ureidopropionase |
| RS770645288 |
SLC27A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Ichthyosis prematurity syndrome, Ichthyosis prematurity syndrome |
| RS770646738 |
ACADS
|
Health Risk |
Likely pathogenic |
Deficiency of butyryl-CoA dehydrogenase, Deficiency of butyryl-CoA dehydrogenase |
| RS770647680 |
NGF
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital sensory neuropathy with selective loss of small myelinated fibers, Inborn genetic diseases |
| RS770648429 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS770648545 |
SRCAP
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS770648642 |
HRAS
|
Health Risk |
Pathogenic |
— |
| RS770648856 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS770649540 |
DHTKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2Q, 2-aminoadipic 2-oxoadipic aciduria |
| RS770649751 |
EVC
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS770649913 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS770652502 |
SRCAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Floating-Harbor syndrome, Developmental delay |
| RS770653972 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS770654508 |
COQ7
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary coenzyme Q10 deficiency 8, Neuronopathy |
| RS770654975 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS770655238 |
AP3D1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS770655669 |
CFI
|
Health Risk |
Conflicting classifications of pathogenicity |
Atypical hemolytic-uremic syndrome with I factor anomaly, Complement-mediated glomerular disease |
| RS770656547 |
OFD1
|
Health Risk |
Likely pathogenic |
— |
| RS770657036 |
POU3F4
|
Health Risk |
Pathogenic |
— |
| RS770657475 |
RELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial temporal lobe epilepsy 7, Norman-Roberts syndrome |
| RS770658506 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS770658701 |
GDAP1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, axonal |
| RS770658726 |
IVD
|
Health Risk |
Conflicting classifications of pathogenicity |
Isovaleryl-CoA dehydrogenase deficiency, Isovaleryl-CoA dehydrogenase deficiency |
| RS770659035 |
CDH23
|
Health Risk |
Pathogenic |
Pituitary adenoma 5, multiple types |
| RS770659908 |
RP1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS770660636 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Colorectal cancer |
| RS770660705 |
SLC6A5
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperekplexia 3, Hyperekplexia 3 |
| RS770661156 |
SERAC1
|
Health Risk |
Conflicting classifications of pathogenicity |
3-methylglutaconic aciduria with deafness, encephalopathy |
| RS770662152 |
GATA6
|
Health Risk |
Conflicting classifications of pathogenicity |
Atrioventricular septal defect 5, Atrioventricular septal defect 5 |
| RS770663172 |
SLC26A5
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 61, Autosomal recessive nonsyndromic hearing loss 61 |
| RS770663802 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
TTN-related disorder, TTN-related disorder |
| RS770663870 |
ACAD8
|
Health Risk |
Likely pathogenic |
Deficiency of isobutyryl-CoA dehydrogenase, Deficiency of isobutyryl-CoA dehydrogenase |
| RS770664202 |
ABCC8
|
Health Risk |
Pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS770664957 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group D1 |
| RS770665020 |
ETFB
|
Health Risk |
Likely pathogenic |
— |
| RS770666285 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuropathy, hereditary sensory |
| RS770666794 |
SPG11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS770666980 |
CREBBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Rubinstein-Taybi syndrome, Menke-Hennekam syndrome 1 |
| RS770667051 |
MYLK
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 7 |
| RS770667157 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS770667248 |
RYR3
|
Health Risk |
Conflicting classifications of pathogenicity |
Epileptic encephalopathy, Epileptic encephalopathy |
| RS770667302 |
CLRN1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS770667508 |
CBL
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Cardiovascular phenotype |
| RS770668926 |
ELP1
|
Health Risk |
Likely pathogenic |
Familial dysautonomia, Familial dysautonomia |
| RS770669224 |
VPS13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Cohen syndrome, Inborn genetic diseases |
| RS770670664 |
FAM149B1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS770670817 |
ZNF687
|
Health Risk |
Conflicting classifications of pathogenicity |
Paget disease of bone 6, Paget disease of bone 6 |
| RS770670938 |
HNRNPU
|
Health Risk |
Conflicting classifications of pathogenicity |
Complex neurodevelopmental disorder, Complex neurodevelopmental disorder |
| RS770671402 |
CBS
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS770671752 |
PIGC
|
Health Risk |
Pathogenic |
Glycosylphosphatidylinositol biosynthesis defect 16, Glycosylphosphatidylinositol biosynthesis defect 16 |
| RS770671793 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Collagen 6-related myopathy, Bethlem myopathy 1A |
| RS770671851 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS770673079 |
ABCA12
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital ichthyosis of skin, Congenital ichthyosis of skin |
| RS770673858 |
ERCC6
|
Health Risk |
Likely pathogenic |
— |
| RS770674396 |
ASXL1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS770674400 |
KAT6B
|
Health Risk |
Pathogenic |
— |
| RS770674513 |
ALPK3
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiomyopathy, familial hypertrophic 27 |
| RS770674615 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS770675734 |
CHRNE
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome 4A |
| RS770676368 |
KIT
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS770677266 |
KCNB1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 26 |
| RS770677319 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS770678862 |
SUFU
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Medulloblastoma |
| RS770678983 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS770679527 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Episodic ataxia type 2, Episodic ataxia type 2 |
| RS770680174 |
SMARCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 16 |
| RS770680602 |
SPEN
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS770681199 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic generalized epilepsy, Hyperaldosteronism |
| RS770681790 |
TULP1
|
Health Risk |
Pathogenic |
— |
| RS770682604 |
PHYH
|
Health Risk |
Likely pathogenic |
— |
| RS770683738 |
FAT4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hennekam lymphangiectasia-lymphedema syndrome 2, Van Maldergem syndrome 2 |
| RS770684431 |
COL7A1
|
Health Risk |
Pathogenic/Likely pathogenic |
7 conditions, 7 conditions |
| RS770684782 |
SETX
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 4, Amyotrophic lateral sclerosis type 4 |
| RS770684838 |
NAGLU
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-III-B |
| RS770684884 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-onset myopathy with fatal cardiomyopathy, Dilated cardiomyopathy 1G |
| RS770685785 |
LMNB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lipodystrophy, partial |
| RS770686014 |
FANCD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group D2, Fanconi anemia |
| RS770686560 |
KCNC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia type 13, Spinocerebellar ataxia type 13 |
| RS770687847 |
SLX4
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS770689762 |
ADA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Sneddon syndrome, Deficiency of adenosine deaminase 2 |
| RS770691402 |
FDXR
|
Health Risk |
Conflicting classifications of pathogenicity |
Auditory neuropathy-optic atrophy syndrome, Auditory neuropathy-optic atrophy syndrome |
| RS770691974 |
SRCAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Floating-Harbor syndrome, Developmental delay |
| RS770692313 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 1 |
| RS770692765 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome 1, Kabuki syndrome |
| RS770692923 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Myofibrillar myopathy 5 |
| RS770692989 |
PTPN23
|
Health Risk |
Conflicting classifications of pathogenicity |
Global developmental delay, Brain atrophy |
| RS770693935 |
ABCB11
|
Health Risk |
Likely pathogenic |
Progressive familial intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |